financetom
Business
financetom
/
Business
/
Pfizer's gene therapy for a muscle-wasting disorder misses main goal of late-stage study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Pfizer's gene therapy for a muscle-wasting disorder misses main goal of late-stage study
Jun 12, 2024 2:02 PM

June 12 (Reuters) - Pfizer ( PFE ) said on Wednesday its

experimental gene therapy for a type of muscle-wasting disorder

did not meet the main goal of a late-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved